A developer of virtual tissue staining systems aided by algorithms for medical images began public operations today, raising $15.2 million in venture funds. . . . → Read More: Virtual Pathology Image Company Opens, Raises $15.2M
|
|||||
A developer of virtual tissue staining systems aided by algorithms for medical images began public operations today, raising $15.2 million in venture funds. . . . → Read More: Virtual Pathology Image Company Opens, Raises $15.2M A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies. . . . → Read More: Biotech, Regeneron in $2B Cancer Antibody Deal A start-up enterprise developing personalized liquid biopsies for finding residual cancer in patients is beginning work and raising $56 million in venture funds. . . . → Read More: Residual Cancer Detection Company Launches, Raises $56M A company discovering therapies with artificial intelligence is partnering with M.D. Anderson Cancer Center on new small-molecule precision medicines. . . . → Read More: Biotech, M.D. Anderson Partner on Precision Drug Design A company developing non-invasive ultrasound treatments for treating skin disorders and removing tattoos received a patent for its technology. . . . → Read More: Patent Awarded for Focused Ultrasound Skin Treatments Interim results from a clinical trial testing personalized therapies invoking the immune system show responses from some patients with advanced liver cancer. . . . → Read More: Trial Shows Results for Personal Cancer Immunotherapies A developer of early-stage non-invasive cancer detection tests based on research in university labs is raising $4 million in its seed venture round. . . . → Read More: Cancer Detection Start-Up Gains $4M in Seed Funds A genomic analytics company says an ethnicity algorithm added to a personal health questionnaire improves risk assessments for breast cancer across all populations. . . . → Read More: AI Analytics Boost Breast Cancer Assessment Diversity Research with lab animals shows an experimental cancer vaccine generates immune-system cells that infiltrate solid tumors and reduce the tumor’s protective environment. . . . → Read More: Dual-Action Vaccine Shown to Attack, Shrink Solid Tumors A new biotechnology company is creating cancer immunotherapies that it says harness more of the full power of T-cells in the immune system to attack tumors. . . . → Read More: Immunotherapy Start-Up Launches Collaboration, Raises $65M |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |